Sage Products – Wound, Ostomy Continence Nurses Society Grants
Grant 1: Sage Products, Inc. – WOCN Society CCI Grant for Incontinence Associated Dermatitis (IAD)
$7,500 for one grant
IAD Grant Priorities:
* Assessing Incontinence Associated Dermatitis
o Differentiating between IAD and Stage 1 and 2 pressure ulcers
o Determining the risk or effect of IAD on pressure ulcers development or severity
* Economic impact of IAD or pressure ulcers
o Cost savings of prevention or treatment in hospital patients, models that predict economic impact of IAD
o Costs of treatment and effects of IAD on length of hospital stay
o Development of models that predict economic impact of IAD while adjusting for various risk factors of hospital patients
* Interventions to prevent or treat IAD
* Effective use of the WOC nurse in preventing or reducing IAD or pressure ulcers
Grant 2: Sage Products, Inc. – WOCN Society CCI Grant for Heel Pressure
$7,500 for one grant
Grant Priorities:
* Determining the incidence of hospital-acquired heel ulcers in acute care facilities, their costs, costs savings of prevention
* Studies of comparative effectiveness of products, devices or practices to prevent or treat heel pressure ulcers
* Interventions to increase patients’ compliance with heel protection
* Development of models that predict economic impact of heel pressure ulcers while adjusting for various risk factors of hospital patients
Eligibility and Terms
Eligibility requirements for application submission:
1. Principal Investigator must be a Registered Nurse with current license but need not have a Masters or Doctoral degree.
2. Novice investigators are encouraged to team with and should identify a more experienced investigator or someone with an advanced degree as part of their research team e.g., co-investigator, project advisor/ consultant, professional mentor.
3. Must be a current member of WOCN.
4. Submit a completed research application form and research proposal.
5. Sign a research agreement (contract) if grant proposal is accepted.
Terms of the grant award include:
1. Agree not to accept duplicate funding (i.e., funding for same project by more than one grant).
2. Application to the appropriate IRB is required within 30 days of grant award notification.
3. The initial grant period and budget are for one year. A no cost extension up to one additional year may be allowed to complete the analysis and make the presentation at the national conference if progress has been satisfactory and a request is made in writing to CENTER FOR CLINICAL INVESTIGATION explaining the need. The request should be made at least 60 days before the end of the grant period. We recommend data collection be completed within first 12 months of the grant so that the abstract submission deadline can be met to the National WOCN conference.
4. Progress report to be submitted after the first 6-months of the grant period to the CENTER FOR CLINICAL INVESTIGATION; final report submitted within 30 days of completion of project.
5. CENTER FOR CLINICAL INVESTIGATION must be notified in writing of plans to terminate the study prior to its completion along with an explanation. Unexpended funds, due to early termination and without a no cost extension, must be returned to the WOCN Foundation via CENTER FOR CLINICAL INVESTIGATION. The CENTER FOR CLINICAL INVESTIGATION Director and Board are available for consultation to troubleshoot issues or problems related to study implementation. PIs are encouraged to use this resource.
6. Manuscript reporting findings of the primary research aims to be submitted to JWOCN for peer-review within four months of completion of the project and final report submission; manuscript may serve as the final report. Submission to JWOCN does not guarantee acceptance for publication.
7. Acknowledgment of the funding source in any and all publications, papers or posters presenting research findings.
8. Agrees to submit an abstract of findings to WOCN conference within 18 months after notification of award and agrees to presentation at WOCN conference if abstract is accepted. An accepted abstract may be selected for an oral or poster presentation.
9. The Principal Investigator is advised to consult the CENTER FOR CLINICAL INVESTIGATION Director regarding major changes to the research protocol after funding. The Principal Investigator should notify the CENTER FOR CLINICAL INVESTIGATION in writing of any major changes to the funded protocol within 30 days of the change.
Terms of the budget:
1. Up to 10% of the total budget can be used for indirect administrative costs.
2. Funds are not to be used as salary support for Principal or Co-Investigators.
3. Permission for rebudgeting greater than or equal to $500 needs to be requested from CENTER FOR CLINICAL INVESTIGATION in writing.
4. Grant recipients are recommended to include travel costs in the budget to attend the annual WOCN meeting to present their findings, unless provides assurance in writing to CENTER FOR CLINICAL INVESTIGATION that other funds are available to travel prior to the award of funds.
5. Funds in the amount of $500 will be withheld until an abstract reporting the study findings and the final report (paper) is submitted to the CENTER FOR CLINICAL INVESTIGATION.
Contact for Questions
Linda Dahle, Program Associate
Center for Clinical Investigation
612-625-8159
cciwocn@umn.edu
Dr. Donna Bliss, Director
Center for Clinical Investigation
bliss@umn.edu
Proposal submission address
WOCN Center for Clinical Investigation
c/o Linda Dahle
Program Associate
120-C Dinnaken Hall
925 Delaware Street SE
Minneapolis, MN 55455
612-625-8159 (Phone)
612-626-8886 (Fax)
dahle081@umn.edu
